Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2011

Mar 10, 2011

32870_dirs_2011-03-10_655fca56-a1e2-4049-acd5-a7c7763885c3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2011-03-08

Reporting Person: Havey Adam (SVP, BioDefense Divison)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-03-08 Common Stock F 536 $21.15 Acquired 4664 Direct